US HB3969 | 2013-2014 | 113th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 29 2014 - 25% progression, died in committee
Action: 2014-02-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 29 2014 - 25% progression, died in committee
Action: 2014-02-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation. Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.
Title
PACT Act
Sponsors
Rep. Bill Johnson [R-OH] | Sen. Marsha Blackburn [R-TN] | Rep. Bruce Braley [D-IA] | Rep. Michael Burgess [R-TX] |
Rep. Peter DeFazio [D-OR] | Rep. Suzan DelBene [D-WA] | Rep. Renee Ellmers [R-NC] | Rep. Morgan Griffith [R-VA] |
Rep. Brett Guthrie [R-KY] | Rep. David Loebsack [D-IA] | Rep. Zoe Lofgren [D-CA] | Rep. Doris Matsui [D-CA] |
Rep. David McKinley [R-WV] | Rep. Pete Olson [R-TX] | Rep. James Renacci [R-OH] | Rep. Tim Ryan [D-OH] |
History
Date | Chamber | Action |
---|---|---|
2014-02-07 | House | Referred to the Subcommittee on Health. |
2014-01-29 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB644 (Related) 2013-03-21 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Child health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health
Licensing and registrations
Prescription drugs
Retail and wholesale trades
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health
Licensing and registrations
Prescription drugs
Retail and wholesale trades
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/113th-congress/house-bill/3969/all-info |
Text | https://www.congress.gov/113/bills/hr3969/BILLS-113hr3969ih.pdf |